Aracelis Torres, PhD, MPH, SVP of Data & Science at Verana Health
In today’s pharmaceutical industry, real-world evidence (RWE) offers significant potential across all phases of the product life cycle, from trial design to product…
Continue Reading
David Karandish, Founder & CEO of Capacity
Urban Health Plan scheduled 794,322 patient visits in 2022. Only 457,722 people showed up.
The missing 336,600 appointments cost the New York health system revenue, burned out their providers…
Continue Reading
Dave Prakash, MD, Director of AI Governance at Booz Allen Hamilton
Kevin Vigilante, MD, MPH, Booz Allen Advisor and former Chief Medical Officer
At the frontline of patient care, providers have been put under impossible pressure…
Continue Reading
Strategic Vision for AI-Powered Services
Tata Consultancy Services (TCS) has unveiled ambitious plans to establish itself as the world’s premier artificial intelligence-powered IT services organization. This strategic pivot represents a fundamental shift in how the…
Martha Thorne, SVP and General Manager, EnlivenHealth
2025 has been a year of hard truths for retail pharmacy.
Persistent reimbursement pressures, escalating fees, workforce shortages and policy whiplash have forced many operators to rethink how they…
Continue Reading
Health systems are expanding artificial intelligence (AI) initiatives across imaging, diagnostics and patient-facing workflows, underscoring the shifting role of the on-premises data center from a legacy infrastructure component to a critical performance layer.The evolution…
Continue Reading
What You Should Know
– Catalyst by Wellstar has launched Polysight, a new AI-native company designed to tackle the $39 billion annual cost of U.S. healthcare compliance.
– The platform uses validated regulatory sources and real-time…
Continue Reading
Kamya Elawadhi, Chief Client Officer, Doceree
Artificial intelligence (AI) has already proven its worth in healthcare marketing by optimizing campaigns—refining targeting, improving efficiency, and reducing waste. But optimization is only the beginning. Its real value…
Continue Reading
Timely identification of harmful brain activities via electroencephalography (EEG) is critical for brain disease diagnosis and treatment, which remains limited in application due to inter-rater variability, resource constraints, and poor generalizability of existing artificial…
Continue Reading
Patients’ voices are often difficult to capture directly in healthcare decisions. This scoping review examines how artificial intelligence (AI) has been applied to measure and predict patient values and preferences, aiming to evaluate its…
Continue Reading
